|
|
Article: Carbon: business absorbed from Adient dissolution helped shop post huge gains.(THE TOP 60)
- Article from:
- Medical Marketing & Media
- Article date:
- July 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CommonHealth's decision to dissolve its professional agency Adient and divide the business between Carbon and Noesis lead to dramatic expansion in 2007, says Darlene Dobry, president. As a result of the merger, Carbon received Ortho-McNeil Pharmaceuticals and Duramed Pharmaceuticals.
Dobry says Ortho-McNeil's Levaquin account was "a lot to take," in the context of an already growing agency. Joe Maynard, who was attached to Ortho-McNeil at Adient, was taken on as a EVE managing director. Other "key personnel" also joined Carbon's ranks.
Carbon was responsible for several new launches in 2007, including Ortho-McNeil's Doribax, an anti-infective indicated ...
Related newspaper, magazine, and journal articles:
|
|
Article: Carbon Hires Director of Client Services.
Business Wire;
November 7, 2006 ;
624 words
... ... and a team leader. Jeanne brings energy, experience and humor to every marketing challenge she is faced with," stated Darlene Dobry, president of Carbon. CommonHealth comprises Carbon, Adient, Altum, Conectics, Ferguson, HLS, MBS/Vox, Noesis ...
|
|